People In Brief
This article was originally published in The Gray Sheet
Executive Summary
Interventional pulmonology CEO: Emphysema device developer Pulmonx announced the hiring of Michael A. Baker as president and CEO July 15. Baker resigned from his 11-year post as CEO of ArthroCare in February in the shadow of an accounting scandal and government investigations (1"The Gray Sheet" Feb. 23, 2009). He also previously served as an executive for Medtronic. The Pulmonx announcement comes two months after the start-up acquired failed endobronchial valve-maker Emphasys Medical and several weeks following 510(k) clearance of its Chartis collateral ventilation detection system, which can be used to identify candidates best suited for lung volume reduction procedures using the Emphasys EBV valve (2"The Gray Sheet" May 18, 2009). Former CEO Ronald Steckel left the firm in November 2008